0
Editorials: POINT/COUNTERPOINT EDITORIALS |

Point: Should We Abandon FEV1/FVC <0.70 To Detect Airway Obstruction? No

Bartolome R. Celli, MD, FCCP; Ron J. Halbert, MD; Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease, updated 2007
Author and Funding Information

From the Pulmonary and Critical Care Division, Brigham and Women’s Hospital, Harvard University School of Medicine (Dr Celli); Cerner Health Insights (Dr Halbert); and Department of Community Health Sciences, UCLA School of Public Health (Dr Halbert).

Correspondence to: Bartolome R. Celli, MD, FCCP, Pulmonary and Critical Care Medicine, Brigham and Women’s Hospital, 75 Francis St, Boston, MA 02115; e-mail: bcelli@copdnet.org


Financial/nonfinancial disclosures: The authors have reported to CHEST the following conflicts of interest: Dr Celli has been reimbursed by GlaxoSmithKline, Boehringer Ingelheim, Pfizer, AstraZeneca, Almirall, Aerys, and Esteve for participating in advisory boards and has spoken at different meetings. The division he works in has been awarded research grants for different medication trials by the same companies and for the discovery of new biomarkers in COPD. The division that Dr Celli works in has received grants for the participation in the development of biologic lung volume reduction surgery from the company AERIS. Dr Halbert serves as a consultant to the biotechnology/pharmaceutical industry, including makers of therapies for COPD.

Reproduction of this article is prohibited without written permission from the American College of Chest Physicians (http://www.chestpubs.org/site/misc/reprints.xhtml).


© 2010 American College of Chest Physicians


Chest. 2010;138(5):1037-1040. doi:10.1378/chest.10-2049
Text Size: A A A
Published online

Extract

COPD is a leading cause of death and disability, but it is underrecognized by the general population, underdiagnosed and undertreated by physicians,1 and underfunded by research agencies.2 Although most national and international bodies agree that COPD should be defined physiologically,3 there are important differences in diagnostic criteria among expert groups. These differences can lead to widely varying prevalence estimates4 that confound the comparability of research studies,5 complicate the assessment of the burden of disease, and contribute to diagnostic confusion.

First Page Preview

View Large
First page PDF preview

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Figures

Tables

References

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Find Similar Articles
CHEST Journal Articles
PubMed Articles
[Progress in research on obstructive sleep apnea syndrome with hypertension]. Zhong Nan Da Xue Xue Bao Yi Xue Ban 2016;41(2):212-7.
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543